A novel technique that uses a virus tagged with a green-glowing jellyfish protein has enabled scientists to visualize the feeding circuit in mice. The method may be useful in studies of other complex circuits in the brain. The findings are reported in the March 30 issue ofÌýScienceÌýby a team of re...

Findings might one day lead to a way to regenerate brain cells for humans Researchers at ÐÓ°É have discovered that a protein known to be involved in the early development of embryos indirectly leads to the formation of nerve tissue in frogs. The findings, reported in the Mar...

Use of microbe’s natural enemy may offer alternative to antibiotics Researchers at ÐÓ°É have discovered a powerful new way to destroy on contact the bacteria that cause strep throat, flesh-eating disease and a variety of other infections. The technique, which may not cause...

New Finding Could Have Major Implications for Treatment of Addiction Scientists have found that an enzyme called Cdk5 regulates the action of chronic cocaine in the brain. In a paper published in the MarchÌýNature,Ìýmembers of Paul Greengard's Laboratory of Molecular and Cellular Neuroscience and...

Body salvages cells by altering genes during halt in development About one-quarter of the body's antibodies are produced by immune cells that have had their genetic code revised during a halt in their development, scientists at Rockefeller University and three other institutions have found. The s...

Finding in Cell Culture Should Boost Studies of Virus and Vaccine Design Researchers at Rockefeller University and Washington University School of Medicine in St. Louis have identified mutations in a protein of certain strains of hepatitis C virus (HCV) that allow these strains to replicate more ...

Mode of invasion may provide clues to the early events of other neurological diseases Researchers at Rockefeller University who study the bacterium that causes leprosy say they have identified a component on the microbe’s surface that allows it to specifically select and attack the peripheral ner...

$4.5 Million Grant from NIH Will Help to Turn Genomic Knowledge into Promising Drug Targets In the wake of the completion of the human genome sequencing project, five New York research institutions have joined together in a collaborative effort to turn that knowledge into promising drug targets. ...

A drug called STI-571, now being tested in clinics to treat a rare form of leukemia, selectively blocks a mutant enzyme that causes the disease without harming its molecular cousins. Reporting in the Sept. 15 issue ofÌýScience, a team of researchers from the Howard Hughes Medical Institute at The ...

A team of researchers from ÐÓ°É in New York and the Yale University School of Medicine has identified for the first time a candidate pheromone receptor gene in humans. The findings, reported in the September issue ofÌýNature Genetics, may shed new light on the molecular basis...